1. Home
  2. TSLX vs VERA Comparison

TSLX vs VERA Comparison

Compare TSLX & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$17.14

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$28.33

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
VERA
Founded
2010
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
TSLX
VERA
Price
$17.14
$28.33
Analyst Decision
Buy
Strong Buy
Analyst Count
11
15
Target Price
$19.77
★ $74.20
AVG Volume (30 Days)
478.0K
★ 1.6M
Earning Date
11-03-2026
11-05-2026
Dividend Yield
★ 10.18%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.15
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.82
$863.11
P/E Ratio
$116.27
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.04
$23.05
52 Week High
$23.19
$56.05

Technical Indicators

Market Signals
Indicator
TSLX
VERA
Relative Strength Index (RSI) 43.37 42.13
Support Level $16.39 $26.38
Resistance Level $17.94 $36.95
Average True Range (ATR) 0.40 1.66
MACD -0.00 0.16
Stochastic Oscillator 41.85 35.68

Price Performance

Historical Comparison
TSLX
VERA

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: